<SEC-DOCUMENT>0001193125-21-252801.txt : 20210820
<SEC-HEADER>0001193125-21-252801.hdr.sgml : 20210820
<ACCEPTANCE-DATETIME>20210820163320
ACCESSION NUMBER:		0001193125-21-252801
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210820
DATE AS OF CHANGE:		20210820

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Montrose Environmental Group, Inc.
		CENTRAL INDEX KEY:			0001643615
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				464195044
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-258732
		FILM NUMBER:		211194276

	BUSINESS ADDRESS:	
		STREET 1:		1 PARK PLAZA, SUITE 1000
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		(949) 988-3500

	MAIL ADDRESS:	
		STREET 1:		1 PARK PLAZA, SUITE 1000
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d200535d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(3) <BR> Registration No. 333-258732<BR> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>P R O S P E C T U S </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>2,921,628 Shares </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g200535g99g91.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Montrose Environmental Group, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling
stockholders identified in this prospectus may offer and sell, from time to time, in one or more offerings, up to 2,921,628 shares of our common stock. We are not selling any common stock under this prospectus and will not receive any proceeds from
the sale of the shares by the selling stockholders. You should carefully read this prospectus and any accompanying prospectus supplement before you decide to invest in the shares that may be offered under this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The distribution of the common stock by the selling stockholders may be effected from time to time by a variety of methods, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in underwritten public offerings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in ordinary brokerage transactions on securities exchanges, including the New York Stock Exchange;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through brokers or dealers who may act as principal or agent; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in one or more negotiated transactions at prevailing market prices or negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The brokers or dealers through or to whom the shares of common stock may be sold may be deemed underwriters of the shares within the meaning
of the Securities Act of 1933, as amended, in which event all brokerage commissions or discounts and other compensation received by those brokers or dealers may be deemed to be underwriting compensation. To the extent required, the names of any
underwriters and applicable commissions or discounts and any other required information with respect to any particular sale will be set forth in an accompanying prospectus supplement. See &#147;Plan of Distribution&#148; for a further description of
how the selling stockholders may dispose of the shares covered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York Stock
Exchange under the symbol &#147;MEG.&#148; On August&nbsp;19, 2021, the last sale price of our common stock as reported on the on the New York Stock Exchange was $44.40 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as defined under the federal securities laws and, as such, may elect to comply with certain
reduced public company reporting requirements for this filing and future filings. See &#147;About the Company&#151;Implications of Being an Emerging Growth Company.&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in the common stock involves risks. You should carefully consider the risks described in &#147;<A HREF="#tx200535_6">Risk&nbsp;
Factors</A> &#148; on page 6 of this prospectus, as well as the other information contained or incorporated by reference in this prospectus and the applicable prospectus supplement, before making a decision to invest in our securities. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this
prospectus is August 20, 2021 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_1">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_2">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_3">Incorporation by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_4">Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_5">About the Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_6">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_7">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_9">Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_8">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_10">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_11">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx200535_12">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a
&#147;shelf&#148; registration process. Under this shelf registration process, the selling stockholders may, from time to time, sell certain shares of our common stock in one or more offerings. When a selling stockholder sells shares of common stock
under this shelf registration process, we may provide a prospectus supplement that will contain more specific information about the terms of such offering. The prospectus supplement may also add to, update or change any of the information contained
in this prospectus. You should carefully read this prospectus, any accompanying prospectus supplement, any free writing prospectuses we have prepared or authorized as well as the information incorporated in this prospectus or any accompanying
prospectus supplement by reference. See &#147;Incorporation by Reference.&#148; Any information in any accompanying prospectus supplement, any free writing prospectus or any subsequent material incorporated herein or therein by reference will
supersede the information in this prospectus or any earlier prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains summaries of certain
provisions in some of the documents described herein, but reference is hereby made to the actual documents for complete information. All of the summaries are qualified in their entirety by reference to the complete text of the actual documents.
Copies of some of the documents referred to herein have been filed or will be filed or incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described
below in the section entitled &#147;Where You Can Find More Information.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither we nor any of the selling stockholders have
authorized anyone to provide any information or to make any representations other than those contained in this prospectus, in any accompanying prospectus supplement or in any free writing prospectuses we have prepared or authorized. You should rely
only on the information provided in this prospectus or any prospectus supplement, including information incorporated by reference herein or therein, or any free writing prospectus that we have specifically referred you to. Neither we nor any of the
selling stockholders take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares offered hereby and only under circumstances and
in jurisdictions where it is lawful to do so. The information contained in this prospectus, any prospectus supplement or any documents we incorporate herein or therein, or in any free writing prospectus, is current only as of the respective dates
thereof. Our business, financial condition, results of operations and prospects may have changed since those respective dates. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
action is being taken in any jurisdiction outside the United States to permit a public offering of common stock or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in
jurisdictions outside the United States are required to inform themselves about and to observe any restriction as to this offering and the distribution of this prospectus applicable to those jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this prospectus and any accompanying prospectus supplement, unless the context otherwise indicates, references to &#147;our,&#148;
&#147;we,&#148; &#147;us,&#148; the &#147;Company,&#148; &#147;Montrose,&#148; &#147;MEG&#148; and &#147;our business&#148; refer to Montrose Environmental Group, Inc. together with its consolidated subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an internet website at
www.sec.gov that contains periodic and current reports, proxy and information statements, and other information regarding registrants, including us, that file electronically with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also make available, free of charge, on or through our Internet website,
<FONT STYLE="white-space:nowrap">www.investors.montrose-env.com,</FONT> our Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> Proxy Statements on Schedule 14A and, if applicable, amendments to those reports filed or furnished pursuant to Section&nbsp;13(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, as
soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information on or that can be accessed through our website is not a part of this prospectus and the inclusion of our website address in
this prospectus is an inactive textual reference only. In addition, you may request copies of these filings at no cost through our Investor Relations Department at: Montrose Environmental Group, Inc., 5120 Northshore Drive, North Little Rock,
Arkansas 72118, telephone: (501) 900-6400. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the Securities Act of 1933, as amended, or the Securities Act, including exhibits, of which this prospectus forms a part, with respect to the shares of common stock that may be offered
hereunder. This prospectus does not contain all of the information set forth in the registration statement and exhibits thereto. For further information with respect to our company and the shares of common stock offered hereby, reference is made to
the registration statement, including the exhibits thereto. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are summaries and are not necessarily complete and you should refer to
the exhibits attached to or incorporated by reference into the registration statement for copies of the actual contract, agreement or other document. Our SEC filings, including the registration statement of which this prospectus forms a part and the
exhibits thereto, are available to you for free on the SEC&#146;s website listed above. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_3"></A>INCORPORATION BY
REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus and any prospectus supplement the
information we file with the SEC. This means that we can disclose important information to you by referring you to another document filed separately with the SEC. Any information referenced in this way is considered part of this prospectus. Any
subsequent information filed with the SEC will automatically be deemed to update and supersede the information in this prospectus and in our other filings with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference in this prospectus the documents listed below that have been previously filed with the SEC as well as any filings
made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act from the initial filing of the registration statement of which this prospectus forms a part until the termination or completion of the offering of the securities
described in this prospectus; provided, however, we are not incorporating by reference any documents or portions of documents deemed to have been furnished rather than filed in accordance with SEC rules: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000156459021015136/meg-10k_20201231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2020, as filed with the SEC on March&nbsp;24, 2021</A>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> from our definitive proxy statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312521103071/d305541ddef14a.htm">Schedule 14A, filed with the SEC on April&nbsp;1, 2021</A>;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarters ended
March&nbsp;31, 2021 and June&nbsp;30, 2021, as filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000156459021027061/meg-10q_20210331.htm">May&nbsp;
12, 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1643615/000156459021043509/meg-10q_20210630.htm">August&nbsp;11, 2021</A>, respectively; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312521005752/d752765d8k.htm">January&nbsp;11,
 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312521073412/d124391d8k.htm">March&nbsp;8, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312521103088/d111318d8k.htm">April&nbsp;
1, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312521140340/d75856d8k.htm">April&nbsp;29, 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312521163646/d162214d8k.htm">May&nbsp;17, 2021</A>; and
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in our registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1643615/000119312520194777/d921936d8a12b.htm">Form
 <FONT STYLE="white-space:nowrap">8-A</FONT> filed with the SEC on July&nbsp;17, 2020</A>, including any amendments or reports filed for the purpose of updating the description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, information furnished under Items 2.02 and 7.01 of any Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K,</FONT>
including the related exhibits under Item 9.01, is not incorporated by reference in this prospectus or any prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
obtain copies of these filings, see &#147;Where You Can Find More Information&#148; above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_4"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, any prospectus supplement and the documents incorporated by reference herein or therein contain &#147;forward-looking
statements&#148; within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act. These forward-looking statements relate to matters such as our industry, business strategy, goals and expectations concerning our
market position, future operations, margins, profitability, capital expenditures, liquidity, capital resources and other financial and operating information. We have used the words &#147;anticipate,&#148; &#147;assume,&#148; &#147;believe,&#148;
&#147;contemplate,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;future,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;position,&#148; &#147;potential,&#148; &#147;predict,&#148;
&#147;project,&#148; &#147;seek,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will&#148; and similar terms and phrases to identify forward-looking statements. All of our forward-looking statements are subject to risks and uncertainties that
may cause actual results to differ materially from those that we are expecting, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our limited operating history; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our history of losses and ability to achieve profitability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general global economic, business and other conditions, the cyclical nature of our industry and the significant
fluctuations in events that impact our business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business operations and on
local, national and global economies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the parts of our business that depend on difficult to predict natural or manmade events and the fluctuations in
our revenue and customer concentration as a result thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the highly competitive nature of our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to execute on our acquisition strategy and successfully integrate and realize benefits of our
acquisitions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to promote and develop our brands; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain and expand our client base; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain necessary accreditations and other authorizations in varying jurisdictions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant environmental governmental regulation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain qualified managerial and skilled technical personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safety-related issues; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">allegations regarding compliance with professional standards, duties and statutory obligations and our ability to
provide accurate results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of formal long-term agreements with many of our clients; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully implement our new enterprise resource planning system; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to adapt to changing technology, industry standards or regulatory requirements;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">government clients and contracts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain our prices and manage costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to protect our intellectual property or claims that we infringe on the intellectual property rights
of others; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">laws and regulations regarding handling of confidential information; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any failure in or breach of our networks and systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our international operations; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product related risks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">environmental regulations and liabilities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional factors discussed in this prospectus, any prospectus supplement and our other SEC filings.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this prospectus and any prospectus supplement are based on historical performance and
management&#146;s current plans, estimates and expectations in light of information currently available to us and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting us will be those
that we have anticipated. Actual results may differ materially from these expectations due to changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors, many of which are beyond our
control, as well as the other factors described in the section entitled &#147;Risk Factors&#148; and in our SEC filings incorporated herein or in any prospectus supplement by reference. Further, many of these factors are, and may continue to be,
amplified by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional factors or events that could cause our actual
results to differ may also emerge from time to time, and it is not possible for us to predict all of them. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove to be incorrect, our actual results may
vary in material respects from what we may have expressed or implied by any forward-looking statement and, therefore, you should not regard any forward-looking statement as a representation or warranty by us or any other person that we will
successfully achieve the expectation, plan or objective expressed in such forward-looking statement in any specified time frame, or at all. We caution that you should not place undue reliance on any of our forward-looking statements. Any
forward-looking statement made by us in this prospectus, in any prospectus supplement or in any document incorporated herein or therein by reference speaks only as of the respective date thereof. We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_5"></A>ABOUT THE COMPANY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The Environment is Our Business. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception in 2012, our mission has been to help clients and communities meet their environmental goals and needs. Today, we have
emerged as one of the fastest growing companies in a highly fragmented and growing global environmental industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our industry is highly
fragmented with no single market leader. By focusing on environmental solutions, we believe we are uniquely positioned to become a leading platform in the industry. We provide a diverse range of environmental services to our private and public
sector clients across the life cycle of their needs &#151;whether they are launching new projects, maintaining operations, decommissioning operations, rehabilitating assets, managing the impacts of climate change or responding to unexpected
environmental disruption. Our integrated platform has been a catalyst for our organic growth and we have built on this platform through strategic acquisitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Innovation is core to our strategy. The world&#146;s environmental challenges continue to grow in number, scope and complexity, and mounting
public pressure and regulatory changes continue to drive demand for better information and solutions. We focus on innovation in order to improve the quality of information we can provide to clients (such as identifying variations of <FONT
STYLE="white-space:nowrap">Per-</FONT> and polyfluoroalkyl substances, or PFAS, in water) and provide better solutions to their environmental needs (such as the efficient removal of PFAS from contaminated water). We intend to continue innovating by
investing in research, development and technology (directly and through strategic partnerships) to develop better solutions for our clients. We believe these investments&#151;together with our investments in geographic expansion, sales and marketing
initiatives, environmental service offerings and strategic acquisitions&#151;will continue to distinguish us in the marketplace. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
revenue and earnings are highly resilient. We are not dependent upon any single service, product, political approach or regulatory framework. We also serve a diverse set of more than 4,500 clients across a wide variety of end markets and geographies
within the private and public sectors. Funding for our services is typically <FONT STYLE="white-space:nowrap">non-discretionary</FONT> given regulatory drivers and public health concerns. As a result, our business is positioned to be less
susceptible to political and economic cycles. Our approach has allowed us to successfully scale our business, and we believe we are well positioned to continue our trajectory and market leadership as we address the growing environmental needs of our
clients and communities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide environmental services to our clients through three business segments &#150; Assessment, Permitting
and Response, Measurement and Analysis and Remediation and Reuse. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Assessment, Permitting and Response </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through our Assessment, Permitting and Response segment, we provide scientific advisory and consulting services to support environmental
assessments, environmental emergency response and environmental audits and permits for current operations, facility upgrades, new projects, decommissioning projects and development projects. Our technical advisory and consulting offerings include
regulatory compliance support and planning, environmental, ecosystem and toxicological assessments and support during responses to environmental disruptions. We help clients navigate regulations at the local, state, provincial and federal levels. In
addition to environmental toxicology, and given our expertise in helping businesses plan for and respond to disruptions, our scientists and response teams have helped clients navigate their preparation for and response to the COVID-19 pandemic. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Measurement and Analysis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through our
Measurement and Analysis segment, our highly credentialed teams test and analyze air, water and soil to determine concentrations of contaminants, including emerging contaminants such as PFAS, as well as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determine the toxicological impact of contaminants on flora, fauna and human health. Our offerings include source and ambient air testing and monitoring, leak detection and advanced analytical
laboratory services such as air, storm water, wastewater and drinking water analysis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Remediation and Reuse </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through our Remediation and Reuse segment, we provide clients with engineering, design, implementation and operations and maintenance services,
primarily to treat contaminated water, remove contaminants from soil or create biogas from agricultural waste. We do not own the properties or facilities at which we implement these projects or the underlying liabilities, nor do we own material
amounts of the equipment used in projects; instead, we assist our clients in designing solutions, managing projects and mitigating their environmental risks and liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were
incorporated in Delaware in November 2013. Our principal executive offices are located at 5120 Northshore Drive, North Little Rock, Arkansas 72118 and our telephone number is (501) 900-6400. Our website address is www.montrose-environmental.com.
Information contained on our website or linked therein or otherwise connected thereto does not constitute part of nor is it incorporated by reference into this prospectus, any prospectus supplement or the registration statement of which this
prospectus forms a part, and the inclusion of our website address in this prospectus is an inactive textual reference only. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an
Emerging Growth Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a company with less than $1.07&nbsp;billion in revenue during our most recently completed fiscal year, we
qualify as an &#147;emerging growth company&#148; as defined in Section&nbsp;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As an emerging growth company, we may take advantage of
specified reduced disclosure and other requirements that are otherwise applicable generally to public companies that are not emerging growth companies. These provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements and
registration statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemption from <FONT STYLE="white-space:nowrap">non-binding</FONT> stockholder advisory votes on executive
compensation or golden parachute arrangements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemption from the auditor attestation requirement in the assessment of our internal control over financial
reporting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may take advantage of these exemptions for up to five years or such earlier time that we are no longer an
emerging growth company. We will cease to be an emerging growth company upon the earliest of: (i)&nbsp;the end of the fiscal year following the fifth anniversary of our initial public offering, which occurred in July 2020; (ii)&nbsp;the last day of
the fiscal year during which our annual gross revenues are $1.07&nbsp;billion or more; (iii)&nbsp;the date on which we have, during the previous three-year period, issued more than $1.0&nbsp;billion in
<FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities; or (iv)&nbsp;the end of any fiscal year in which the market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeded
$700.0&nbsp;million as of the end of the second quarter of that fiscal year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As June&nbsp;30, 2021, the end of our second fiscal quarter,
the market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeded $700.0&nbsp;million and, as a result, we will no longer qualify as an emerging growth company as of December&nbsp;31, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have elected to take advantage of certain reduced disclosure obligations in the documents incorporated by reference in this prospectus, and
we may elect to take advantage of other reduced disclosure obligations in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
future filings with the SEC while we remain an emerging growth company. If we do, the information that we provide stockholders may be different than what you might receive from other public
reporting companies in which you may have equity interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The JOBS Act permits an emerging growth company such as us to take advantage
of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have chosen to &#147;opt in&#148; to this extended transition period for complying with new or revised accounting standards and,
as a result, we will not be subject to the same new or revised accounting standards as other public companies that comply with such new or revised standards on a <FONT STYLE="white-space:nowrap">non-delayed</FONT> basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties and other factors
described in &#147;Risk Factors&#148; in any prospectus supplement. You should also consider the risks, uncertainties and other factors described in &#147;Risk Factors&#148; and elsewhere in our most recent Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K,</FONT> as supplemented and updated by subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> that we have filed or will file with the SEC, and in other documents which are incorporated by
reference in this prospectus, as well as the risk factors and other information contained in or incorporated by reference in any accompanying prospectus supplement and any related free writing prospectus. If any of these or any unanticipated risks
actually occurs, our business, financial condition and results of operations could be materially and adversely affected and the trading price of our common stock could decline, causing you to lose some or all of your investment in our common stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic may amplify many of the risks to which we are subject and,
given the unpredictable, unprecedented and fluid nature of the pandemic, it may materially and adversely affect us in ways that are not anticipated by or known to us or that we do not presently consider to present significant risk. Therefore, we are
unable to estimate the extent to which the pandemic and its related impacts will adversely affect our business, financial condition and results of operations as well as our stock price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders will receive all proceeds from the sale of the shares of common stock offered by this prospectus and any accompanying
prospectus supplement. We will not receive any of the proceeds from the sale of our common stock by the selling stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_9"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are party to an investor rights agreement with certain of the selling stockholders and certain other holders of shares of our common stock.
The terms of the investor rights agreement include provisions for certain demand registration rights and piggyback registration rights in favor of the selling stockholders. The registration statement of which this prospectus forms a part was filed
in connection with a demand for registration by certain of the selling stockholders under the investor rights agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares
offered by this prospectus may be offered from time to time by the selling stockholders. The selling stockholders may sell some, all or none of their shares. We do not know how long the selling stockholders will hold the shares offered hereunder
before selling them. The selling stockholders may have sold or transferred, in transactions exempt from the registration requirements of the Securities Act, some or all of their respective shares since the date on which the information in the table
below is presented. Information about the selling stockholders may change over time. As used in this prospectus, the term &#147;selling stockholders&#148; includes the selling stockholders listed below, and any donee, pledgee, transferee or other
successor in interest selling shares received after August 6, 2021 from a selling stockholder as a gift, pledge, or other <FONT STYLE="white-space:nowrap">non-sale</FONT> related transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the name of each selling stockholder, the number of shares of our common stock and the percentage of our common
stock beneficially owned by each selling stockholder prior to this offering, the number of shares that may be offered under this prospectus by each selling stockholder, and the number of shares of our common stock and the percentage of our common
stock to be beneficially owned by each selling stockholder after completion of this offering, assuming that all shares offered hereunder are sold as contemplated herein. The number of shares in the column &#147;Maximum Number of Shares That May Be
Offered&#148; represents all of the shares that the selling stockholder may offer under this prospectus. There were 26,199,377&nbsp;shares of common stock outstanding as of August&nbsp;6, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power over securities. Except in
cases where community property laws apply or as indicated in the footnotes to this table, we believe that each stockholder identified in the table possesses sole voting and investment power over all shares of common stock shown as beneficially owned
by the stockholder. Shares of common stock subject to options and warrants that are exercisable or exercisable within 60&nbsp;days of August 6, 2021 are considered outstanding and beneficially owned by the person holding the options for the purpose
of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of common&nbsp;stock</B><br><B>beneficially&nbsp;owned&nbsp;prior&nbsp;to<BR>this offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>common&nbsp;stock</B><br><B>offered&nbsp;pursuant&nbsp;to&nbsp;this<BR>prospectus</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of common&nbsp;stock<BR>beneficially owned after<BR>this offering
(assuming<BR>the&nbsp;sale&nbsp;of&nbsp;all&nbsp;shares&nbsp;that&nbsp;may&nbsp;be&nbsp;sold<BR>hereunder)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Selling Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>of<BR>common<BR>stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of total<BR>outstanding<BR>common<BR>stock (%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;of<BR>common<BR>stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of&nbsp;total<BR>outstanding<BR>common<BR>stock (%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO WFH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO EAH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO TWH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO HDH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO MOH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO RMG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO HHG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO OWG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO CRH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO WCH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO AWH</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBO GC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Richard E. Perlman Irrevocable Trust FBP AP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasym Afsari<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">198,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.&nbsp;Miguel Fernandez
de&nbsp;Castro<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">145,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter Graham<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joshua LeMaire<SUP STYLE="font-size:85%; vertical-align:top">(1)(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">213,293</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">213,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vijay&nbsp;Manthripragada<SUP STYLE="font-size:85%; vertical-align:top">(1)(3)(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">434,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">434,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robin Newmark<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard E. Perlman<SUP STYLE="font-size:85%; vertical-align:top">(3)(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,421,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,419,036</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J. Thomas Presby<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James K. Price<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,060,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,058,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jose Revuelta<SUP STYLE="font-size:85%; vertical-align:top">(1)(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents less than one percent. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Executive officer of the Company. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares beneficially owned by Ms.&nbsp;Afsari include 181,293 shares of common stock issuable upon exercise of
stock options that have vested or will vest within 60 days of August 6, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Board of Directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares beneficially owned by Mr.&nbsp;LeMaire include 200 shares of common stock held by Joshua W. LeMaire and
Lori R. LeMaire and 213,093 shares of common stock issuable upon exercise of stock options that have vested or will vest within 60 days of August 6, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares beneficially owned by Mr.&nbsp;Manthripragada include 422,014 shares of common stock issuable upon
exercise of stock options that have vested or will vest within 60 days of August 6, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 342,797 shares of common stock held by Equity Trust Company, Custodian FBO Richard E. Perlman Roth
IRA. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares beneficially owned by Mr.&nbsp;Revuelta include 213,093 shares of common stock issuable upon exercise of
stock options that have vested or will vest within 60 days of August 6, 2021. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_8"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material provisions of our capital stock, as well as other material terms of our amended and restated
certificate of incorporation and our amended and restated bylaws. This summary does not purport to be complete and is subject to and qualified in its entirety by our amended and restated certificate of incorporation and our amended and restated
bylaws, copies of which are incorporated by reference as exhibits to the registration statement of which this prospectus forms a part. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>General </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized
capital stock consists of 190,000,000&nbsp;shares of common stock, par value $0.000004 per share, and 10,029,500&nbsp;shares of preferred stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended
and restated certificate of incorporation authorizes the issuance of up to 190,000,000&nbsp;shares of common stock. All outstanding shares of common stock are validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of stockholders and our amended and
restated certificate of incorporation does not provide for cumulative voting in the election of directors. Subject to preferences that may be applicable to any outstanding series of preferred stock, the holders of our common stock will receive
ratably any dividends declared by our board of directors out of funds legally available for the payment of dividends. In the event of our liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> the holders of our common stock
will be entitled to share ratably in all assets remaining after payment of or provision for any liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series <FONT
STYLE="white-space:nowrap">A-1</FONT> Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has designated 12,000 shares of preferred stock as
Cumulative Series <FONT STYLE="white-space:nowrap">A-1</FONT> Preferred Stock. We redeemed and retired all outstanding shares of Series <FONT STYLE="white-space:nowrap">A-1</FONT> preferred stock in July 2020 in connection with our initial public
offering, or the IPO. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has designated 17,500&nbsp;shares of preferred stock as Cumulative
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> Preferred Stock. As of the date of this prospectus, there were 17,500&nbsp;shares of the <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock issued and outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective immediately upon consummation of our IPO, the certificate of designation for the
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock granted holders of our <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock the right to receive cumulative dividends, accruing daily and compounded
quarterly, at a rate of 9.0% per annum, on the then-stated value of each share of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock (initially $10,000 per share). Prior to the IPO, the certificate of designation for the <FONT
STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock granted holders of our <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock the right to receive cumulative dividends, accruing dividends at the rate of 15% per
annum, with respect to dividends that were paid in cash, and 14.2% per annum, with respect to dividends that accrued before a private offering, and 9.0% following a private offering (in certain circumstances), on the then-stated value of each share
of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock (initially $10,000 per share), and dividends accrue whether or not earned or declared by our board of directors, and in preference to the holders of any and all other series or
classes of capital stock, with the stated value increased by the amount of any accrued dividend. We may not issue any equity securities ranking equal or senior to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock so long as any shares of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock remain outstanding, other
than (i)&nbsp;with the consent of the holders of at least a majority of the stated value of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock then outstanding, or (ii)&nbsp;permitted indebtedness up to a maximum of 4.5 times
our trailing twelve month adjusted pro forma EBITDA (as calculated pursuant to the terms of the certificate of designations of the <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as required by Delaware law or as otherwise provided by our certificate of incorporation or the certificate of designation with respect
to certain protective matters, the holders of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock do not have any voting rights. Notwithstanding the foregoing and for so long as any shares of
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock are outstanding, the holders of a majority of the outstanding shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock will have the right, voting as a
separate class, to elect one director, to serve until the earlier of the time his or her successor is appointed or elected, unless such director is earlier removed, resigns or is otherwise unable to serve. Additionally, if certain events of
noncompliance have occurred, are continuing and have not been cured within 30&nbsp;days of notice thereof, the holders of a majority of the outstanding shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock will have the right,
voting as a separate class, to elect an additional director, to serve until the earlier of the time such event of noncompliance has been cured, there ceases to be any shares of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock
outstanding or his or her successor is appointed or elected, unless such director is earlier removed, resigns or is otherwise unable to serve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may, at our option, redeem some or all of the outstanding shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock, in
no less than $25.0&nbsp;million increments (unless less than $25.0&nbsp;million of the stated value of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock is then outstanding), at a price per share equal to the sum of the then-stated
value per share plus any accrued and unpaid dividends not accounted for in the then-stated value, plus (to the extent such redemption occurs prior to the third anniversary of the issuance of the
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock), a make whole amount as of such redemption date equivalent to the remaining dividends that would accrue with respect to such shares prior to the three-year anniversary of the
issuance. At any time after the fourth anniversary of the issuance of the <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock, the holders of the <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock will have
the option to require us to convert, initially, up to $60.0&nbsp;million aggregate stated value of the <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock into shares of our common stock, with the permitted amount of <FONT
STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> preferred stock to be converted increasing at each subsequent anniversary of the issuance in $60&nbsp;million increments until the sixth anniversary, after which all of the Series <FONT
STYLE="white-space:nowrap">A-2</FONT> preferred stock may be converted at the holder&#146;s option; provided, that until the seventh anniversary, no more than $60.0&nbsp;million aggregate stated value may be converted in any <FONT
STYLE="white-space:nowrap">60-day</FONT> period; and provided, further, that for a period of ninety (90)&nbsp;days following notice of a holder&#146;s election to have its shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock
converted, we will have the option to redeem for cash such shares elected to be converted in lieu of converting them into shares of common stock. Each share of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock we do not elect to
redeem for cash will be convertible into the number of shares of common stock equal to the sum of the then-stated value plus all accrued and unpaid dividends, divided by the conversion price. The conversion price is equal to 85% of the
volume-weighted average price of our common stock for the ten trading days immediately preceding the conversion date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The certificate of
designations includes certain restrictive covenants, including with respect to restricted payments, dividends and other payments to common stockholders and the consummation of certain acquisitions without consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the directorship described above, the holders of Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock are
entitled to the following remedies during any period when we are not in compliance with certain terms of the certificate of designations following a cure period of 30&nbsp;days after notice thereof (except in connection with a failure to pay
dividends when due): an increase in the annual dividend rate from 9% per annum to 12% per annum for the first 90&nbsp;day period from and including the date on which such event of noncompliance occurred and 14% thereafter, and restrictions on our
ability to declare any dividends or distributions, or otherwise repurchase, redeem or acquire any of our or our subsidiaries&#146; capital stock, or to consummate acquisitions otherwise permitted by the terms of the certificate of designations. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary of the terms of the Series <FONT STYLE="white-space:nowrap">A-2</FONT>
preferred stock is not complete and is subject in its entirety to the complete text of the certificate of designations, the form of which is incorporated by reference as an exhibit to the registration statement of which this prospectus forms a part
and is incorporated herein by reference. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorization Following this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that our board of directors has the authority, without further action by the
stockholders, to issue up to 10,000,000 additional&nbsp;shares of preferred stock. Our board of directors is able to issue preferred stock in one or more series and determine the rights, preferences, privileges, qualifications and restrictions
granted to or imposed upon our preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption, liquidation preferences and sinking fund terms, any or all of which may be greater than the rights of our
common stock. Issuances of preferred stock could adversely affect the voting power of holders of our common stock and reduce the likelihood that holders of our common stock will receive dividend payments and payments upon liquidation. Any issuance
of preferred stock could also have the effect of decreasing the market price of our common stock and could delay, deter or prevent a change in control of our company. Our board of directors does not presently have any plans to issue shares of
preferred stock. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Limitations on Directors&#146; Liability </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our governing documents limit the liability of, and require us to indemnify, our directors to the fullest extent permitted by the Delaware
General Corporation Law, or the DGCL. The DGCL permits a corporation to limit or eliminate a director&#146;s personal liability to the corporation or the holders of its capital stock for breach of fiduciary duty. This limitation is generally
unavailable for acts or omissions by a director which (i)&nbsp;were not in good faith, (ii)&nbsp;were the result of intentional misconduct or a knowing violation of law, (iii)&nbsp;the director derived an improper personal benefit from (such as a
financial profit or other advantage to which the director was not legally entitled) or (iv)&nbsp;breached the director&#146;s duty of loyalty. The DGCL also prohibits limitations on director liability under Section&nbsp;174 of the DGCL, which
relates to certain unlawful dividend declarations and stock repurchases. The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders
from bringing a lawsuit against directors for breach of their fiduciary duties. These provisions may also have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful,
might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we pay the settlement costs and damage awards against directors and officers pursuant to these indemnification provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain insurance that insures our directors and officers against certain losses and which insures us against our obligations to indemnify
the directors and officers. We have also entered into indemnification agreements with our directors and executive officers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exclusive
Forum Clause </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that, unless we consent in writing to the selection of an
alternative forum, to the fullest extent permitted by law, the sole and exclusive forum for any stockholder (including any beneficial owner) to bring (i)&nbsp;any derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting
a claim of breach of a fiduciary duty owed by any of our directors, officers or employees to us or to our stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL or our certificate of incorporation or
bylaws or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine, is a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction or declines to accept
jurisdiction, the federal district court for the District of Delaware); in all cases subject to such court having personal jurisdiction over the indispensable parties named as defendants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our amended and restated certificate of incorporation provides that the federal
district courts of the United States are the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act but the forum selection provisions do not apply to claims brought to enforce a duty or liability
created by the Exchange Act. Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of discouraging
lawsuits against us or our directors or officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring any interest in shares of our
capital stock is deemed to have notice of and consented to the foregoing provisions. See &#147;Risk Factors&#148; in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> incorporated herein by reference. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Delaware Takeover Statute </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to Section&nbsp;203 of the DGCL, an anti-takeover statute. In general, Section&nbsp;203 prohibits a publicly held Delaware
corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a period of three years following the time the person became an interested stockholder, unless (with certain exceptions) the business
combination or the transaction in which the person became an interested stockholder is approved in a prescribed manner. Generally, a &#147;business combination&#148; includes a merger, asset or stock sale or other transaction resulting in a
financial benefit to the interested stockholder. Generally, an &#147;interested stockholder&#148; is a person who, together with affiliates and associates, owns (or within three years prior to the determination of interested stockholder status, did
own) 15% or more of a corporation&#146;s voting stock. The existence of this provision would be expected to have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, including discouraging attempts
that might result in a premium over the market price for the shares of common stock held by stockholders. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Provisions of Our Certificate
of Incorporation, Bylaws and Delaware Law That May Have an Anti-Takeover Effect </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions of the DGCL and our amended and restated
certificate of incorporation and amended and restated bylaws could make it more difficult to acquire our company by means of a tender offer, a proxy contest or otherwise, or to remove incumbent officers and directors. These provisions, summarized
below, are intended to discourage coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of these provisions
outweigh the disadvantages of discouraging certain takeover or acquisition proposals because, among other things, negotiation of these proposals could result in an improvement of their terms and enhance the ability of our board of directors to
maximize stockholder value. However, these provisions may delay, deter or prevent a merger or acquisition of us that a stockholder might consider is in its best interest, including those attempts that might result in a premium over the prevailing
market price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Requirements for Advance Notification of Stockholder Meetings, Nominations and Proposals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that special meetings of the stockholders may be called only by or at the
direction of the board of directors, the chairman of our board or the chief executive officer with the concurrence of a majority of the board of directors or at the written request of one or more stockholders who own shares representing at least 45%
of the voting power of the stock outstanding and entitled to vote on the matters to be brought before the proposed special meeting and who comply with specified procedural requirements in our amended and restated bylaws. Our amended and restated
bylaws prohibit the conduct of any business at a special meeting other than as specified in the notice for such meeting. These provisions may have the effect of deferring, delaying or discouraging hostile takeovers or changes in control or
management of our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws establish advance notice procedures with respect to
stockholder proposals and the nomination of candidates for election as director. In order for any matter to be &#147;properly brought&#148; before a meeting, a stockholder will have to comply with such advance notice procedures and provide us with
certain information. Our amended and restated bylaws allow the presiding officer at a meeting of stockholders to adopt rules and regulations for the conduct of meetings which may have the effect of precluding the conduct of certain business at a
meeting if such rules and regulations are not followed. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#146;s own slate of directors or otherwise attempting
to influence or obtain control of our company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Supermajority Voting for Amendments to Our Governing Documents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any amendment to our amended and restated certificate of incorporation requires the affirmative vote of at least 66<SUP
STYLE="vertical-align:top">2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the voting power of all shares of our common stock then outstanding. Our amended and restated certificate of incorporation provides that the board of directors
is expressly authorized to adopt, amend or repeal our bylaws and that our stockholders may amend our bylaws only with the approval of at least 66<SUP STYLE="vertical-align:top">2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the voting
power of all shares of our common stock then outstanding. However, to the extent a holder or an affiliated group of holders of our Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock owns more than 45% of our outstanding common stock,
which includes shares of common stock issued upon conversion of the Series <FONT STYLE="white-space:nowrap">A-2</FONT> preferred stock, the affirmative vote of at least a majority of the voting power of the stock outstanding and entitled to vote
thereon, voting together as a single class, will be required for the stockholders to adopt, amend or repeal, or adopt any provision inconsistent with, any provision of our amended and restated certificate of incorporation or our bylaws, as
applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Cumulative Voting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The DGCL provides that a stockholder&#146;s right to vote cumulatively in the election of directors does not exist unless the certificate of
incorporation specifically provides otherwise. Our amended and restated certificate of incorporation does not provide for cumulative voting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Classified Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
amended and restated certificate of incorporation provides that our board of directors is divided into three classes of directors, with the classes to be as nearly equal in number as possible, designated Class&nbsp;I, Class&nbsp;II and
Class&nbsp;III. The terms of Class&nbsp;I, Class&nbsp;II and Class&nbsp;III directors end at our 2024, 2022 and 2023 annual meetings of stockholders, respectively. Commencing with the 2024 annual meeting of stockholders, directors of each class the
term of which shall then expire shall be elected to hold office for a three-year term. The classification of directors has the effect of making it more difficult for stockholders to change the composition of our board of directors. Our amended and
restated certificate of incorporation provides that the number of directors will be fixed from time to time exclusively pursuant to a resolution adopted by the board of directors, but must consist of not less than three or more than
15&nbsp;directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Removal of Directors; Vacancies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws provide that directors may be removed only for cause and
only upon the affirmative vote of holders of at least 66<SUP STYLE="vertical-align:top">2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the voting power of all the then outstanding shares of stock entitled to vote generally in the
election of directors, voting together as a single class. In addition, our amended and restated certificate of incorporation and amended and restated bylaws provide that any newly created directorships and any vacancies on our board of directors
will be filled only by the affirmative vote of the majority of remaining directors. Therefore, while stockholders meeting the applicable requirements may call a special meeting for the purpose of removing directors, stockholders are not able to
elect new directors to fill any resulting vacancies that may be created as a result of such a special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Action by Written Consent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The DGCL permits any action required to be taken at any annual or special meeting of the stockholders to be taken without a meeting, without
prior notice and without a vote if a consent in writing, setting forth the action so taken, is signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a
meeting at which all shares of stock entitled to vote thereon were present and voted, unless the certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation and amended and restated bylaws preclude
stockholder action by written consent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification of Officers and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The DGCL authorizes corporations to limit or eliminate the personal liability of officers and directors to corporations and their stockholders
for monetary damages for breaches of directors&#146; fiduciary duties. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that eliminate, to the extent allowable under the DGCL, the personal
liability of officers and directors for monetary damages for actions taken as an officer or a director, as the case may be. Our amended and restated certificate of incorporation and amended and restated bylaws also provide that we must indemnify and
advance reasonable expenses to our officers and directors to the fullest extent authorized by the DGCL. We are also expressly authorized to carry directors&#146; and officers&#146; insurance for our officers and directors as well as certain
employees for certain liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in our amended and restated certificate of
incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against officers and directors for breach of their fiduciary duty. These provisions may also have the effect of reducing the likelihood of derivative
litigation against officers and directors, even though such an action, if successful, might otherwise benefit our company and our stockholders. In addition, your investment may be adversely affected to the extent that, in a class action or direct
suit, we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At
present, there is no pending litigation or proceeding involving our directors or officers for whom indemnification is required or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for
indemnification. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized but Unissued Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Our authorized but unissued shares of common stock and preferred stock are available for future issuance without stockholder approval. The DGCL
does not require stockholder approval for any issuance of authorized shares. However, the rules of the New York Stock Exchange&nbsp;require stockholder approval of certain issuances equal to or exceeding 20% of the then-outstanding voting power or
the then-outstanding number of shares of common stock. No assurances can be given that our shares will remain so listed. We may use additional shares for a variety of corporate purposes, including future public offerings to raise additional capital,
corporate acquisitions and employee benefit plans. As discussed above, our board of directors has the ability to issue preferred stock with voting rights or other preferences, without stockholder approval. The existence of authorized but unissued
shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of our company by means of a proxy contest, tender offer, merger or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Opportunities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recognition
that certain directors, principals, members, officers, employees and other representatives of Oaktree Capital Management, L.P. and its affiliated entities and funds and their respective affiliates (other than us), which we refer to as the Oaktree
Entities, may serve as a member of our board of directors, and that the Oaktree Entities or any representative thereof who serves on our board of directors, who we refer to as an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Oaktree Director, may engage in the same or similar activities or related lines of business that we do or other business activities that overlap or compete with our business, our amended and
restated certificate of incorporation provides for the allocation of certain corporate opportunities between us and the Oaktree Entities. Specifically, none of the Oaktree Entities or any Oaktree Director has any duty to refrain from engaging,
directly or indirectly, in a corporate opportunity in the same or similar activities or related lines of business that we do or that we may propose to engage in or from otherwise competing with us. In the event that any Oaktree Entity or Oaktree
Director acquires knowledge of a potential transaction or matter which may be a corporate opportunity for itself and us, we will not have any expectancy in the corporate opportunity, and no Oaktree Entity or Oaktree Director will have any duty to
communicate or offer the corporate opportunity to us and may pursue or acquire such corporate opportunity for itself or direct such opportunity to another person. In addition, if an Oaktree Director acquires knowledge of a potential transaction or
matter which may be a corporate opportunity for us and an Oaktree Entity, we will not have any expectancy in the corporate opportunity unless the corporate opportunity is expressly offered to the person solely in his or her capacity as one of our
directors. See &#147;Risk Factors&#148; in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> incorporated herein by reference. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Transfer Agent and Registrar for our common stock is Computershare Trust Company, N.A. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Listing </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock
is listed on the NYSE under the symbol &#147;MEG.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_10"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders may offer and sell, from time to time, some or all of the shares of common stock covered by this prospectus.
Registration of the shares of common stock covered by this prospectus does not mean, however, that those shares necessarily will be offered or sold, or if they are, that they will be sold pursuant to this prospectus. We will not receive any proceeds
from any sale by the selling stockholders of their shares of common stock. See &#147;Use of Proceeds.&#148; We will pay all costs, expenses and fees in connection with the registration of the shares of common stock, including fees of our counsel and
accountants, fees payable to the SEC and fees of counsel to the selling stockholders. The selling stockholders will pay all underwriting discounts and commissions and similar selling expenses, if any, attributable to the sale of the shares of common
stock covered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders may sell the shares of common stock covered by this prospectus from time to
time, at market prices prevailing at the time of sale, at prices related to market prices, at a fixed price or prices subject to change or at negotiated prices, in any manner permitted by the Securities Act, including any one or more of the
following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in privately negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through broker-dealers, who may act as agents or principals; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a block trade in which a broker-dealer will attempt to sell a block of shares of common stock as agent but may
position and resell a portion of the block as principal to facilitate the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through one or more underwriters on a firm commitment or best-efforts basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through selling agents; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any combination of the above. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In effecting sales, brokers or dealers engaged by a selling stockholder may arrange for other brokers or dealers to participate. Broker-dealer
transactions may include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchases of the shares of common stock by a broker-dealer as principal and resales of the shares of common stock
by the broker-dealer for its account pursuant to this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary brokerage transactions; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transactions in which the broker-dealer solicits purchasers. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time a particular offer of the shares of common stock covered by this prospectus is made, a prospectus supplement, if required, will be
distributed which will set forth the aggregate amount of shares of common stock covered by this prospectus being offered and the terms of the offering, including the name or names of any underwriters, dealers, brokers or agents, any option under
which underwriters may purchase additional shares of common stock from the selling stockholder(s), any discounts, commissions, concessions and other items constituting compensation from the selling stockholder(s) and any discounts, commissions or
concessions allowed or reallowed or paid to dealers. Such prospectus supplement, and, if necessary, a post-effective amendment to the registration statement of which this prospectus is a part, will be filed with the SEC to reflect the disclosure of
additional information with respect to the distribution of the shares of common stock covered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the
sale of the shares of common stock covered by this prospectus through underwriters, underwriters may receive compensation in the form of underwriting discounts or commissions and may also receive commissions from purchasers of shares of common stock
for whom they may act as agent. Underwriters may sell to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they
may act as agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any underwriters, broker-dealers or agents participating in the distribution of the shares
of common stock covered by this prospectus may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act, and any commissions received by any of those underwriters, broker-dealers or agents may be deemed to be underwriting
commissions under the Securities Act. The selling stockholders may also be deemed to be an underwriter, and any discounts and commissions it receives and any profit it realizes on the sale of the common stock may be deemed to be underwriting
commissions under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling stockholders may enter into hedging transactions with broker-dealers or other financial
institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of shares of common stock in the course of hedging transactions, broker-dealers or other financial institutions may engage
in short sales of shares of common stock in the course of hedging the positions they assume with a selling stockholder. Selling stockholders may also sell shares of common stock short and redeliver the securities to close out such short positions.
Selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of shares of common stock offered by this
prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus, as supplemented or amended to reflect such transaction to the extent required. Selling stockholders may also pledge shares of common
stock offered hereby to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged securities pursuant to this prospectus, as supplemented or amended to
reflect such transaction to the extent required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders may enter into derivative transactions with third parties, or
sell shares of common stock to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell shares of common stock covered by this prospectus
and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use shares of common stock pledged by a selling stockholder or borrowed from a selling stockholder or others to settle those sales or to close
out any related open borrowings of stock, and may use shares of common stock received from such selling stockholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will
be an underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a post-effective amendment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may authorize underwriters, dealers and agents to solicit from third parties offers to purchase shares of common stock under contracts
providing for payment and delivery on future dates. The applicable prospectus supplement will describe the material terms of these contracts, including any conditions to the purchasers&#146; obligations, and will include any required information
about commissions we may pay for soliciting these contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Agents, underwriters and dealers may be entitled under agreements which may
be entered into with us or selling stockholders to indemnification by us or selling stockholders against specified liabilities, including liabilities incurred under the Securities Act, or to contribution by us or selling stockholders to payments it
may be required to make in respect of such liabilities. The prospectus supplement will describe the terms and conditions of such indemnification or contribution. Some of the agents, underwriters or dealers, or their affiliates may be customers of,
engage in transactions with or perform services for us or our subsidiaries in the ordinary course of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the
offering, the underwriters may purchase and sell shares of common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by
the underwriters of a greater number of shares than they are required to purchase in the offering. &#147;Covered&#148; short sales are sales made in an amount not greater than the underwriters&#146; option to purchase additional shares from the
selling stockholders in the offering. The underwriters may close out any covered short position by either exercising their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to close out
the covered short position, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the
overallotment option. &#147;Naked&#148; short sales are any sales in excess of such option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the
underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of various bids for
or purchases of common stock made by the underwriters in the open market prior to the completion of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters may
also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter
in stabilizing or short covering transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases to cover a short position and stabilizing transactions may have the effect of
preventing or retarding a decline in the market price of the Company&#146;s stock, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price of the common stock. As a result, the price of the
common stock may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain underwriters, agents or dealers or their affiliates may have provided from time to time, and may provide in the future, investment,
commercial banking, derivatives and financial advisory services to the Company, the selling stockholders and their respective affiliates in the ordinary course of business, for which they have received or may receive customary fees and commissions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, a selling stockholder that is an entity may elect to make a pro rata <FONT STYLE="white-space:nowrap">in-kind</FONT>
distribution of securities to its members, partners or stockholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. Such members, partners or stockholders would thereby receive freely tradeable
securities pursuant to the distribution through the registration statement of which this prospectus is a part. To the extent a distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus supplement in
order to permit the distributees to use the prospectus to resell the securities acquired in the distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the shares of
common stock covered by this prospectus may be sold in private transactions or under Rule 144 under the Securities Act rather than pursuant to this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered hereby will be passed upon for us by Gibson, Dunn&nbsp;&amp;&nbsp;Crutcher LLP. Certain
legal matters in connection with the shares of common stock offered hereby may be passed upon for any underwriters, dealers or agents by counsel named in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx200535_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements incorporated in this Prospectus by reference from the Company&#146;s Annual Report on Form 10-K for the
year ended December&nbsp;31, 2020, have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report, which is incorporated herein by reference. Such financial statements have been so
incorporated in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>2,921,628 Shares </B></P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g200535g99g91.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Montrose Environmental Group, Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>August&nbsp;20, 2021 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g200535g99g91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g200535g99g91.jpg
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M 0$! 0$! 0$! ?_  !$( "D _@,!$0 "$0$#$0'_Q  =   #  (# 0$
M       '" D%!@ $"@,"_\0 01   00" 0," P,'"@4%     P$"! 4&!P@
M$1(3% D5(2(V=18C,4%VL[07)#(T-3=1<[6V,SAT@;(8)W'$Q?_$ !T!  $$
M P$!              <" P4&  $(! G_Q !%$0 " @$# @,%!0,*! 4%   !
M @,$!081$@ A!Q,Q%"(R08$546%QL2-"P0@D,U)B<I&AT? 6-4.R-%-T@K,E
M<X72X?_:  P# 0 "$0,1 #\ ]_'6=9U,7?\ S"9B.^\0J,9DK88MK:RD SD4
M0C7#O+"T&M;=UX?M^F4N-5[RLAN<YC69 Z6(R*.(Q[^*?%?Q\DP7BOIJEA)6
MM8'1ER>/4\<#@IE;5^,TLE40;\'?#4W<569E RQGCD!2!6: N9=8;:QQD,D#
M<9B#\1;LZCU&Z#\O?W'RZI-2755DE/5Y!1S065/<P8ME63XSO($N%,"P\<XU
M5$5$>-[55KT:]CN["-:]KFIV3CLC2R]"EE,;9CN8_(5H;E.U">4<]:Q&LL4J
M$['9D8'9@&4[JP# @3J.LB+(C!D=0RL.X((W!'64Z]O2NII\J.6),&VMA.+X
M;*28/7EV&^SD<<WB*RF28AH+\5<5OV%4%'/G^]54,,%A8Q$<UDVI(QO&?CKX
MXV=-:[TKAM-3>?'I+*QY?4Z0R;1WIYH)*CX)I!NO[/%V[?M!/F)%;MU]PMF@
MRK!7\JL%A(HR&\E@TVQ[;D;>7N-^X4G?[F(^:D"A6)9719QC5+EV-3AV-%?P
M V-=+'V[N"9/M",SNJAE1BM)&F1G]BQ9831RHTHGM3K;!9O&ZDP^.SN'L+;Q
MN4JQVZDZ^K1R#NDB[DQSPN'AL0M[\,\<D4@#HP$S%*DT:2QL&210RD?<?D?N
M(.X(]000>XZV+J6Z<ZYUG6=3YY/<IET1R1X[XY86KH6%9#7Y S/XKBHR&E;D
MUG64='?2VN7Q;^35C5RK%)'BI&P%M8X5_G1$Z"^O=;V=+Z^T+7]I:/#6(,BF
M=@Y[0O!DIZM6E=E7TY8V>K).LFW(0M:C3^E8=4C46IX\)G<'6EEX5K"3>V M
MLHCGD2&&9O\ [$D;OOZ\.8'Q'J@R*BHBHO=%^J*GU147]"HO1HZN_4_N1?*/
M\A>3/&[2%%:NCDO\QIIN?MCE\4=7Y6:1B>,4<U6KXJ*1*GR[N7%-V4:Q:&:B
M>+ANZ#.N=;6<;KO0.F<?9:*.?+UK&>\M]A+7O^;C*%&;;L8VDL2W9HGV(:&C
M,/W3U2<[J9*.H,%AHY0KV;,+6P&_<M.:U>)N_P"\S-*RGOL(6'J-Z ]&;J[=
M3WQ_>FQ^4NV,VP?1N31]?Z?UC*'69;M6+5UU]DF67!BR0,J\-%;AE4L"#(="
MG/#:NB33CA1P6KGL2R@USPC'J;5'B%J3)X?2.373FE<$X@R6I(:E:]E,I9<N
M@KXI;J2TZT+F.4I9,,TBQ(EGD//AKFE5<W;U%DKE3$3K5QF.816<BJ)--9E8
MLHCJB3E&BG@Y$G%R$59"1YB1D@9SH+=M;4RK?3O)G9Z9E$$^3%JMDGQ;)\7N
MI F=VP7A'B\$5+[E45J2?9648;U8CH;&JXS/9F/#_6=:N]S27B=JM<O$IDCK
M:CDQ65QEQU':%HABX(Z?F>GF"&Q&K;?L5W,@D;>)RB1-)C<W=]I4$JEXP3P2
MD=^! @01<O3EQ=1V]T=ST/.'?,RTW/D>2:;VQ31,7W+AR6/KABC=#BWS*.;\
MNO8SZ\I3?+LAI97A\P@@.6/,#[F;"%%!#D@%Y_"[Q*R6IK%W36JZ<5#4^+$O
M-X4,,-Y:TOD6E:NS/[/=K/Q\Z*.1HIE+RPI$D3HL7I?5IRUFQB<A$M;+5/,Y
M)\ F\E_+F7RR28YX6VYH"0PY.@548#9N>F\\OX^ZZUQG>&RF!G,V]2PK*'([
MNK[VD=BF929U#9B:GF^%/?'CD5XWC/%D18\N,]DD B,]GC)J;-Z3PFG\O@IO
M+LQ:JI^TPN.5>_0^S,L;%"T@[M!.PB8LI62*6**:)EEC1E].LLW/@:%&[7(#
M')Q1NC?!+$:UIWB<#OQ?@.XV*D!E(8 ]'K0F^<%Y#Z_K\\PB8BM>K8=_1'(Q
MUKC%XP3"2J>S&WQ[N9YH6%,:QL>QA/%+C]FO<,=WTCJS&:QPT&7QK%.0$=RG
M(0;%"V%!DK3@;;[$[Q2@!)XBLB;;E5E\)FZ.>HI=I/N/@GA)'FUY@ 6BD'X;
M[HVW&1"&7UV .YTYGGVJ=/R]F:\SR\Q:ZK[_ !FH="#'H9]-+B6TTL OJQ;:
MCL3"D^I)";W$>2+Z 1CF/:O;JD>,5O46&TS)G--9Z_BK\-S'UO)CBQ]BG+#/
M,\+\X;E&RZR<I$;S(Y%[1A2I';J+U?>MXK%/D:EJ2"2.:O$4 B>)EE<QG=9(
MG(;=@>08>FQ'1KV-AFS+#7U7AFOM@7-3DT[(*1EMLJS953+>EI8DEUM<63:X
M JF#/+-6"*E!518PPN2U09FBKARC@M&H,+J.QIZOA<#J*]3R4UZD+.I;"U)K
MM2I#-[9;L"O''5KS-.8%II6CB6/C:X,$KJ[)+W:UYZ<=:G;D2=YHA)>D$;21
M1*?,ED\L>6KE^ B$:@ ^9L0$#$)ARF?R(XY:?G;*B<GLIR:9#NZ&H973,!U_
M717MM9#XY3/,*JF'\Q^*/&G?Z_5'N=W[H)O$&EXC:+TS+FZGB?E\E8BM4ZRU
MYL!IV"(K8<H[EEI2OR78%>_YD^O56U)-E\!BWR'VY-.4FABX-3JHI\TE=]PC
M'<;;];]K'!N1^TM08+L*#RPR6EMLUPNFR1($G6V!6%=#F6U>.9[7U@PH$MT5
MCRH)#)^>:U%*C7N[#ZF,%IOQ'S^F<3F$\5\K3N93%5;K02:<T]/7AGLP+*8P
MR58)?+5FXA@>8'O>\?=Z]N.@S62Q=._'GY8GN5(K 1J-5T5I4#\=P%;B"=M_
M7Y['TZ+&SY6Q\7XKRLQF9?>XSL_ ],-R&\F5_P BECFY?38K"GW3;4$^JLX,
ML9;2#,"YT1D=$;*.^.].XG,M6HDU'3\-C?.:R&.U/AM)+:M6:OL,HL9>KC8)
M;9MQV:=J&97M02J3$L>RRR&-@2I61ORW*FG7N23RP7J>*]HF9?*;>S%65Y1(
M&21&!D1@>/R9BIWV(6CCZ?DOOSCW'VM0\B[ZJSN7,R2/4TT_$L!DXI*/1V$B
M'&AS5_)EDT*6"@:PDYSY0X3BJ5($EHU$\<Z,J>)NK]$)J&MXD9.IGGEOI6J3
MXC3TN*D:I,\444P^RA.GG\ &G+2+"6YB"0+Q,'@Y\SG,(N2KY>2.T[6%BC>M
M5-=FA=D"M^P#CF5 +^\$WWX-ML2YP;Y/9%R*Q/,Z_.:^'#SS6MO755])KP>S
MC646W99)72S04<X<.R9)I;:+8!C*V(YT<1XXH[3.CBNOA!KK+ZRQ62@U#!#'
MF\%9AK6YZ\1@BM16%F\F5H-RL5E7JV(["1;0DJCQI&',:^W2&HY,_7MI815M
MX^6.*<H.*N)?,X,5]%<-#(KA?=[ J!OL-MY4<F2:.C8=AV&4\7+MR[3MP4&O
M\7D%<V(,LF7'KTNKAH2!,L%L^9%A1(R'B.L)1#>,H,:!/*&6\0]<6-*P8_'8
M6G'D]49^PM/#T92WD(SR)#[7;",CF(2R)'%$)(O/D+?M42&5E]&H]0KAO9*E
M>-;.5R4JP4JQ/;=F6,2R $'AYC*BKNO-B=F"HY'=K]#[5NZ<,O8/)?:@\Q.%
MII+=<KB>(XA5S'M\_:5]4N*RYUC"B/7T$DV4YDBP$/URAB%*K!^*+06J+U59
ML_XF:M7+2*'<:=;$X?$U93W\JO4&*EFL0Q':/G9G\RPB\V6)W(7T1XK(2Q*U
MW-WO:2-V]B%>M61B/A2/R&>15/8,[@OMR*J6(Z4//>1O(#A;LW',?W?=@W'I
MG+B%^2YHVFA4V50HD4H!60E6O&$)[NE;*CRY5;9.L!W,,P'U]M *20*"/+NK
M?$+PKU!2H:LR*ZSTGD2?9<H:4%/+00HR+."U98TDMU?,622"T;"VXF3R;<#-
M(L%6R&H<MI3(5X<Q(N1Q=HGR;8B6*=55@)![NP,T(=6:-^8E0KPE0E@E/9V8
MT43"9FP 2VV6-1L5D9B&= 5#,GT0:E]V.7"=W1"ME0&H:.O=$>A&+W1%ZZ)E
MR56/%RYA'\^DE!\DDD.S>=56N;2O$>P;S(@&3N =QU?WMPK3>\KB2NM9K8=.
MX>$1&8.GWAH^Z_?N.D5X\6.PN76 6NWK_=><8("SR:]J,9PO5,V@I:W$(=08
M3(X+V7-H;2TO[4Z$%,,LZ4 ;X,@#QB$.4(<4)Z/KZD\3,3:U+E-:Z@P(L9"W
M7QN&TK/0H5<3!68"-+DLU"S:R%E^2RN;$J*T+J515D58JE@;%O4U&3*29.S5
M62Q+%!5Q[0QI66(@!9F:*1YI&W#GFR@HRD* RA6MTC4;&J]=OH-H9+89)E=;
MD&9U#<J-#!6S[2CBY#9Q,;N&!8!!,)*I60I@GD;)[.(U'GF-8ARDO1E'4%/3
MWV=J7*V,IE*]W+51EGBCKV+--+UF/'V@JQ\ [4_)D5F638D!GF YM8\4EY*9
MBR$S36$GM1>>4$;21)/(L$H4#8<X@CC?EZ[<FVW,_P"^V9NV5SI+QEIMXY91
MXA-A)8Q)JT."VES :W6KLS?&::7C+1RANGA( 9#C4K(9&L>\QQJ=X2O7]>R^
M+TFAZ6NLQ1P4L8FBF^S\!:N5]L!]IF,2S8H+*IM*T:M(I<0L S.Z\VI4V5R3
M:Q.G8\G/% Z^8K^55DE0?9YN%?>@ (Y@J">X4@'=O>+E8IK/>&.[#BDR'>61
M9_@4S#LA:<5ACN*8_*I<KCW6)K2.1U'&C$LA650;)$17 8. ^O5"N(^<!!E'
M$Z8UKCL_')D==Y//X.7$7T>*QCL10DIY1+F+--P:$,+6%GJMD!WC"P&'WBQF
M3C;*]+*P75\[)RW*;5IN7.&O"T5A9:_E?T04R"2(S_(!#'W)+KL/>;?)V/H?
M"(V-X].8/9F>ADQ:!!N1Q\?IV*D>QR=XT[N8=CR)!HD>C6FLW$E,0XZF7'?7
M?''Q&L:(TV:.%9CJ;.1RUZ#Q]WQM7;A9RA [B9.7DT =@;3&<<TJ2QMY-2YZ
M/$0) CCVVVK>4-^\40[/.1\N_N1;[<GW(Y"-AU/:FU-IG!J'#\&Y#9F;#]\<
MBOMZSAR'D>/70&--(I+?/VK(&E>S-+H8<><ED,AO<2T@Q4AS85[.JZ#X6?R+
ML[K?PPU;JK+T;:9LTXKM*5VE\W"[.ME%>L/^8WYXF]KS-1N4M#&;(IAR,@5A
MUD]5:2TSD,#I[5&93&Z@U?(5Q$$CC:FHY^SV,FQ=?98;]H+1@>0?M;#^4O'R
MK4L!PX=;OR#3.SK'B?N/U*@Y;@\3#73BJHZS(Y*^Y;31I!.PS4>7#(RQQZ0%
MR!+9R1MCL,Z^1P(3P'U/G=#9^[X3:RBEK1QW)4PTD[$QT\@Y\QJ<,C>[)CLN
MK"WCY4(0V9 8T<Y M';L'F6H9%L#D3Y3O*4K\V^&=MBL0)[&.QOR@8=F<C;D
M9>S@<PN2=?QWURAH4F.[8&8K+J,)@D]-ZQB"$SYEDD@+T<U\.A'(CN8Q["#D
MVDJMBD&Z,62\1N\8?$%]!:6FFQ_&34.4$M/"Q, P@?@//R<J-N&BH(ZLB,&6
M:U)6B=3$\K).ZBSD.&JKNZ^UVN<=5"1O[H'F3$?U8@R_@SLBGL20H/';A*[8
MNN,BSK<<FVAY-L6M-*P]"E.ZTH5GF99 S.X&4K"3K2WD(,S:V6]$6H/)64]L
MVR8M9SWX;?R=(]3:;R^H->27(LSJ:M))A?,>1KF-:>06DSM]6=6LW+LH5_9)
MFV]BDF,S"S;!IQF(PKVZ;VKS2)+;0M "6YQA_>%B1=QR=SL0A/\ 1D\CR?W,
M%QBVYDO%_=$_C-N4GR^DR*Y$#'IYR/=6UV06;FAJ+2KE%1B/QG,404=S_%K8
M=JL8LD<$S;Q$=\&<YJ#PIUA=\+]8(T>+O7/_ *?89F:K4R$Y JW*<S <L7FE
M"JVX40VQ&\BUY!>!\.+R[X;*'#9-O+2>15A=C[BRR':)T8^L%@[+N1[LG'EP
M(EZLGUVQT0NN=9UG4'N:^L)O)3?_ "IB4#I$O)>,_';6=C10(SR/]Q:3[*RS
M^PJEC,[^O,M,1G7@ZX*)ZA;)U<C>[45.@9KK2G_%F<S\P4O8P> QZ4AWV:7V
MB:]-&5_>:2M+,J#U\PI]W7/VMZSZDU'K*O49WN:1TSBK$<*$GE+,\N2>'B/B
MDFHO/Y*#8M*8N^W3<\".8.+[.X?GSO-\@!'LM!4MA1;/GR3-=('48E3NLZC)
M#L5WK&^:XL +7R']WV%[77(Q*\C%3J]:*S9L:6BDR#D6,- U:Z[;EFBJ1<H;
M!W]YC)650S'N\Z2^IZM?AUK_ !N<T3-E;EM%?3<,L.9D<@,D%. SPVV7?D5F
MJ*/>/]+8BL*NY4]27Y0NR;&<8X\\X<T%+K\QWAN+)=CF@&(YRT.#Q'89::;Q
ML7=/35L#$L?F6$8W9#FC6X12?(D3[(AU'I^TSX76EJ-OM3)9J?)R@[EJ]*)J
M3X>LGW>16K,Z-MN1* W=!T(M79&?'X[2^OLAYD-G469M9,1DG>#'CV*?"U@/
M39*5=Y4;NS+,H?=E.WH7Y,Y588QQIWGF..'<EA3Z<V!>5,Z*]?*.2/B5G*CV
M8'M^O\R:B3QN:OZ HO?]?1]U%),FG\U)5)$XQ-\P.AV*N:LG"12/FA(<;?-1
MUTCJJ\]'2NH,C7;WJV#R-J*13\/ETI9!,I'_ )8'F#;UX]('\&6TK+?C1GDN
M(41;!N[+^/8*CFJ9HAX3@)(+7)_30'B:0H5=]%*Z5XK]'(E"\'\>F.TY>B"A
M97S,\DG8<N/L5%8__:.+;?B6Z'G@??@R.ELA/%(LCKGK,<I'Q#C0QS("/4+L
MS%=^Q)?;Y]5UZ*_1EZ\_65RVX?\ &?QZJQER!-D5S1V-A!C_ &6HW(M0D3)G
MO8WZ.]R#W]Q(5R+W,<A>Z*C5:!9\.:GC##D:B<//GBEEX; ?SC$&*V2!Z^8#
M)*V^^[L6W!V(YSNY!*7CC5Q]9]I+4U>5X5!]+.%+6B=NQ#())VWW]XEOD-GY
MY]SH0K/AA4V<:/,K,BYH:BHIT*4$<B//C6H;VK/!E1S>0)$*6">8,R.9A!G
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M#%"\DTTI]%ABC>5F]T(6[=37X5Z%V)N?F)M_XB>W<9ML(H\E),HN/6$Y%%)
MR1,:^1PL+A9M<5KW^=4A,&K6UD2,1'-M9N0WUH!%KX]386L/A:OVCDK&HYJL
ME<3>Y16=>$S1>6L G,9')%:%>*;_ !\W<;IP=PCX;Z1SV?\ $C4GB[J2O-CJ
M=TR5=(8BRK16TI^S18V/)6HN7[$G%P"%(R")Y;EJ=?V4=>:?>_BFWL>EM^"<
MH]M%K@4O,W6&8VB'.,+QT6,2?4M+)SG.:X,6O9-'[B2JH$*R1*5456=;U7=I
MTVP1MNJ[YFLZ<F *^6=VE[]PL?(;L/3<?AU,>.#2K8\+GBL)"E/Q'P>3MAB
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M8;@$C?;?8D?,]-SUZ]I/+LP0V(]^7ESQ),G( @-PD5EW 8C?;?8D>A/6*Q[
M\&Q&1*EXIAF)XQ*G"''FRL>QVGI9$P 7N($$H];#C$D"$]SGC&5SV,>YSFM1
M55>FJ]&E49GJTZM9G 5VKUXH6=5)(#&-%+ $D@$D D[=,UL?0ILSTZ-.J[J%
M=JU:&!G522%9HD4LH)) )(!)(ZRE[C]!E%:>ER:DI\BIY:(DJIO:V%;ULE&]
M^R'@6 9$4R)W7LA!.[=UZ=F@@LQM#8ABL1-\44T:2QM_>1PRGZCIZQ6KVXF@
MM00V8'^.&Q$DT3?WHY%9&^H/0TQ[COH#$;5E[BND-18W=#(A@V]%KC#ZFRCD
M_4^/.@TX),9>_P!?S!!IY*KNWDJKU'5\!@ZDGG5<-BJ\P.XE@Q]2*13_ &72
M)67Z$??U%5M-:<IS"Q4P&%JS@\EFKXNE#*I^]9(X%=?_ &D=&/J6ZF^M&M]8
MZUR&SDW-]KW!KRXFH!)EK;XG06=G+2*%D:,DF=-@'E'2/'$..!"E>@@C8(?B
MQC6IXY<=CYY&FGHTYI7VYRRU8))&X@*O)W0LW%0%&Y.P  [#J/GQ.*LRM/9Q
MF/L3/QYS3TZTLK\5"KRDDC9VXJ J[D[* !V ZV2DH:/&JV/38Y356/T\13.B
MU5)70ZJMC+(.23(6/!@!!%"IY)BR#*,35*<I"O\ (CW.5^&&&O&L->**")-^
M,4,:11KR8LW%$"J.3$L=@-V))[D]>J"O7JQ+!6@AK0IRX0P1)#$G)BS<8XU5
M%Y,Q9M@-V))[D]<N*FDR"$>COZRJNZV8T3Y-1<0XEE"E-C2!2 O/7S1F =L>
M4$!Q.(%R"D"$5BM(QCDW+#%/&T4\4<T3;<HY462-N+!EY(X*G9@&&X[, 1W
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..S\ _/_7I ^,_E_IU_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
